Skip to search formSkip to main contentSkip to account menu

rogletimide

Known as: 3-PYG, 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione, Pyridoglutethimide 
An orally active aminoglutethimide derivative with potential antineoplastic activity. Rogletimide reversibly inhibits the activity of aromatase, a… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
SummaryThe conversion of androgens to estrogens occurs in a variety of cells and tissues, such as ovarian granulosa and… 
Highly Cited
1992
Highly Cited
1992
The influence of the prototype aromatase inhibitor Aminoglutethimide (AG) and its analogue Rogletimide (RG) on peripheral… 
Review
1992
Review
1992
Aminoglutethimide was the first aromatase inhibitor to be used in breast cancer therapy but, since it interacts with the… 
1992
1992
Analysis of the proton NMR spectra of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione (rogletimide, 1) shows that it exists in solution… 
1990
1990
The inhibitory effects of pyridoglutethimide (3-ethyl-3-(4-pyridyl)piperidine-2,6-dione), an analogue of aminoglutethimide, on…